Forest Celexa

Citalopram co-promotion agreement with Warner-Lambert will be terminated immediately, Forest announces May 12. Forest will pay Warner-Lambert $14 mil. to terminate the agreement and Warner-Lambert will be excluded from any profits recorded after April 30. Forest reported earlier in May that its sales force has been expanded from 850 to 1,425 representatives, resulting in a decrease of net income for the quarter ending March 31. Warner-Lambert's merger partner Pfizer markets the competing antidepressant Zoloft. The termination agreement contains provisions "limiting Warner-Lambert employees previously involved in marketing or selling Celexa from marketing or selling" Zoloft for a specified period of time, Forest said